Theoretical study on pegylation reaction mechanisms of IFN-α-2a, IFN-α-2b and IFN-β-1a

Main Article Content

Mohammad Taqavian
Daryoush Abedi
Fatemeh Zigheimat
Leila Zeidabadinejad

Abstract

Ab initio and DFT calculations have been carried out to study the reaction mechanism between IFN-α-2a, IFN-α-2b and IFN-β-1a and polyethylene glycol (PEG) group. The calculations show that the mechanisms are concerted in agreement with the results of experimental works. However, although it appears that there is one single transition state, the characteristics of its structure reveal a very synchronous reaction mechanism. The reactions are clearly exothermic and as well have feasible activation energies. Our computational study shows that the lowest transition state energies are related to Lys 134, His 34 and Met 1 of IFN-α-2a, IFN-α-2b and IFN-β-1a, respectively.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Article Details

How to Cite
[1]
M. Taqavian, D. Abedi, F. Zigheimat, and L. Zeidabadinejad, “Theoretical study on pegylation reaction mechanisms of IFN-α-2a, IFN-α-2b and IFN-β-1a”, J. Serb. Chem. Soc., vol. 82, no. 7-8, pp. 841–850, Aug. 2017.
Section
Theoretical Chemistry

References

G. Sen, P. Lengyel, J. Biol. Chem. 267 (1992) 5017

S. K. Tyring, Am. J. Obstet. Gynecol. 172 (1995) 1350

M. Peters, Hepatology. 23 (1996) 909

R. G. Tsanev, I. Ivanov, Immune interferon: properties and clinical applications, CRC Press, Boca Raton, FL, 2001

B. Perussia, M. Kobayashi, M. E. Rossi, I. Anegon, G. Trinchieri, J. Immunol. 138 (1987) 765

K. Fantes, In Vitro Monogr. 3 (1974) 48

J. Parkin, B. Cohen, Lancet. 357 (2001) 1777

V. Gaberc-Porekar, I. Zore, B. Podobnik, V. Menart, Curr. Opin. Drug. Disc. Dev. 11 (2008) 242

T. Thomas, G. Foster, Int. J. Nanomedicine. 2 (2007) 19

J. Frey, R. Peck, W. Bollag, Cancer. Lett. 57 (1991) 223

S. Maher, A. Romero-Weaver, A. Scarzello, A.M. Gamero, Curr. Med. Chem. 14 (2007) 1279

P. Bailon, W. Berthold, J. Pharm. Sci. 1 (1998) 352

D. Baker, Rev Gastroenterol Disord. 3 (2002) 93

Y.-S. Wang, S. Youngster, J. Bausch, R. Zhang, C. McNemar, D. F. Wyss, Biochem. J. 39 (2000) 10634

H. Yano, S. Ogasawara, S. Momosaki, J. Akiba, S. Kojiro, S. Fukahori, H. Ishizaki, K. Kuratomi, Y. Basaki, S. Oie, Liver. Int. 26 (2006) 964

M. Talpaz, H. Kantarjian, R. Kurzrock, J. M. Trujillo, J. U. Gutterman, Ann. Intern. Med. 114 (1991) 532

H. M. Kantarjian, S. O'Brien, T. L. Smith, M. B. Rios, J. Cortes, M. Beran, C. Koller, F. J. Giles, M. Andreeff, S. Kornblau, J. Clin. Oncol. 17 (1999) 284

L. D. Jacobs, D. L. Cookfair, R. A. Rudick, R. M. Herndon, J. R. Richert, A. M. Salazar, J. S. Fischer, D. E. Goodkin, C. V. Granger, J. H. Simon, Ann. Neurol. 39 (1996) 285

R. A. Rudick, N. Simonian, J. Alam, M. Campion, J. Scaramucci, W. Jones, M. Coats, D. Goodkin, B. Weinstock-Guttman, R. Herndon, Neurology 50 (1998) 1266

Y. Mitsui, T. Senda, T. Shimazu, S. Matsuda, J. Utsumi, Pharmacol. Ther. 58 (1993) 93

G. Uzé, G. Lutfalla, K. E. Mogensen, J. Interferon. Cytokin. Res. 15 (1995) 3

R. Camble, N. Petter, P. Trueman, C. Newton, F. Carr, R. Hockney, V. Moore, A. Greene, D. Holland, M. Edge, Biochem. Biophys. Res. Commun. 134 (1986) 1404

J. M. Harris, R. B. Chess, Nat. Rev. Drug Discov. 2 (2003) 214

S. P. Monkarsh, Y. Ma, A. Aglione, P. Bailon, D. Ciolek, B. Debarbieri, M. C. Graves, K. Hollfelder, H. Michel, A. Palleroni, Anal. Chem. 247 (1997) 434

K. R. Reddy, M. W. Modi, S. Pedder, Adv. Drug Deliv. Rev. 54 (2002) 571

P. Bailon, A. Palleroni, C. A. Schaffer, C. L. Spence, W.-J. Fung, J.E. Porter, G. K. Ehrlich, W. Pan, Z.-X. Xu, M. W. Modi, Bioconjugate Chem. 12 (2001) 195

C. Dhalluin, A. Ross, W. Huber, P. Gerber, D. Brugger, B. Gsell, H. Senn, Bioconjugate Chem. 16 (2005) 518

Y.-S. Wang, S. Youngster, M. Grace, J. Bausch, R. Bordens, D. F. Wyss, Adv. Drug Deliv. Rev. 54 (2002) 547

D. P. Baker, E. Y. Lin, K. Lin, M. Pellegrini, R. C. Petter, L. L. Chen, R. M. Arduini, M. Brickelmaier, D. Wen, D. M. Hess, Bioconjugate Chem. 17 (2006) 179

M. Frisch, G. Trucks, H. B. Schlegel, G. Scuseria, M. Robb, J. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. Petersson, Gaussian 09, revision A. 02, Gaussian, Inc., Wallingford, CT, 2009

S. Huzinaga, Comput. Phys. Rep. 2 (1985) 281

M. M. van Beers, W. Jiskoot, H. Schellekens, J. Interf. Cytokin. Res. 30 (2010) 767.